Market Place
Sourcing Support
Legend, J&J tap Novartis for commercial production of Carvykti
29 Mar 2024 //
FIERCE PHARMA
NeoImmuneTech to Present Data on NT-I7 in Combo with CAR-T tisagenlecleucel
04 Nov 2022 //
PRNEWSWIRE
Novartis five-year Kymriah data show durable remission and long-term survival
12 Jun 2022 //
GLOBENEWSWIRE
FDA approves Novartis Kymriah CAR-T cell therapy for r/r follicular lymphoma
27 May 2022 //
PRNEWSWIRE
Novartis Kymriah® receives EC approval as first CAR-T cell therapy
04 May 2022 //
NOVARTIS
Novartis has an idea why Kymriah failed in 2L lymphoma
15 Dec 2021 //
FIERCEPHARMA
Blackstone bets on Autolus` CD19 CAR-T in $250M deal
09 Nov 2021 //
WALLSTREETJOURNAL
Priority review for Novartis CAR-T cell therapy Kymriah
26 Oct 2021 //
PHARMATIMES
CRISPR Therapeutics` CAR-T Cancer Therapy Shows Early Promise
13 Oct 2021 //
BIOSPACE
NeoImmuneTech Begins Dosing in Phase 1b Study of NT-I7 and Kymriah in r/rLBCL
13 Oct 2021 //
BUSINESSWIRE
Novartis` CAR-T fails to help a vulnerable group of NHL patients
24 Aug 2021 //
ENDPTS
Losartan is not effective in reducing hospitalization in mild COVID-19
18 Jun 2021 //
SCIENCEDAILY
HHS inspector general signs off on Novartis paying for pricey Kymriah
26 Mar 2021 //
ENDPTS
Singapore approves first commercial CAR-T therapy by Novartis
10 Mar 2021 //
BIOSPECTRUMASIA
Novartis receives approval for Kymriah® (tisagenlecleucel)
09 Mar 2021 //
PRESS RELEASE
MHLW Orders Label Revisions for NSAIDs, Salbutamol, Kymriah
02 Mar 2021 //
JIHO
5 years later, CAR-T pioneer Kymriah offers jaw-dropping evidence
18 Feb 2021 //
ENDPTS
CRISPR-edited CAR-T cells show enhanced activation against leukemia in mice
07 Dec 2020 //
FIERCE BIOTECH
Novartis makes its Kymriah case in follicular lymphoma
07 Dec 2020 //
FIERCE PHARMA
Novartis Expands Kymriah Manufacturing Footprint
03 Nov 2020 //
CONTRACTPHARMA
Novartis adds Japanese site to Kymriah manufacturing network
31 Oct 2020 //
FIERCE PHARMA
Novartis fills MFG gap for CAR-T therapy Kymriah first Asian production
30 Oct 2020 //
FIERCE PHARMA
Autolus provides glimpse of next-generation CAR-T program
18 Sep 2020 //
ENDPTS
From natural killer cells to off-the-shelf CAR-Ts, biopharma targets cancer
15 Sep 2020 //
FIERCEBIOTECH
Virus makes solid tumors vulnerable to CAR-T attack in mice
02 Sep 2020 //
FIERCEBIOTECH
FDA clears NeoImmuneTech’s IND for combination therapy to treat B-cell lymphoma
25 Aug 2020 //
PHARMABIZZ
NeoImmuneTech Receives U.S. FDA IND Clearance for Phase 1b Study of NT-I7
24 Aug 2020 //
BUSINESSWIRE
Novartis eyes 3rd Kymriah indication in follicular lymphoma
05 Aug 2020 //
FIERCE PHARMA
FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T
04 Aug 2020 //
ENDPTS
Navigating Complexity in Oncology Cell and Gene Therapy Clinical Trials
24 Jul 2020 //
CLINICALTRIALSARENA
ASCO: Momentum gathers behind next wave of CAR-T therapies
01 Jun 2020 //
PMLIVE
Novartis Kymriah Receives FDA RMAT Designation
22 Apr 2020 //
PRESS RELEASE
Novartis Kymriah Gets FDA RMAT Designation In Follicular Lymphoma
21 Apr 2020 //
NASDAW
Novartis Kymriah® receives FDA Regenerative Medicine Advanced Therapy
21 Apr 2020 //
PR NEWSWIRE
Bristol-Myers finds FDA receptive to speedy review of key cell therapy
13 Feb 2020 //
BIOPHARMADIVE
Kymriah pioneer Carl June is back, with first US human evidence for CRISPR
07 Feb 2020 //
ENDPTS
HHS Clears Novartis to Cover Travel Expenses for Some Kymriah Patients
01 Feb 2020 //
FIERCE PHARMA
Novartis’ Kymriah travel assistance program gets HHS green light
31 Jan 2020 //
FIERCE PHARMA
Novartis announces landmark steps for Kymriah® (tisagenlecleucel)
28 Jan 2020 //
MEDIANET
NOVARTIS WITHDRAWS THE KYMRIAH® PATENT, A VICTORY ACHIEVED THROUGH
16 Dec 2019 //
MEDCINEDUMONDE
Novartis still hasn`t solved its CAR-T manufacturing issues
12 Dec 2019 //
BIOPHARMADIVE
Novartis` new facility could ease Kymriah manufacturing woes
02 Dec 2019 //
FIERCE PHARMA
Novartis`s $90 million Swiss factory to help solve cell therapy bottleneck
01 Dec 2019 //
REUTERS
Celgene posts pivotal CAR-T data ahead of FDA filing
08 Nov 2019 //
FIERCE BIOTECH
Aldevron, NTC Team Up for Gene Therapy Manufacturing
24 Oct 2019 //
CONTRACT PHARMA
GSK taps Lyell Immunopharma to take cell therapy to the next level
09 Oct 2019 //
FIERCE BIOETCH
CAR-T with a new target could address cancer relapses
25 Sep 2019 //
FIERCE PHARMA
Penn team adapts CAR-T tech, reengineering mouse cells to treat cardiac fibrosis
12 Sep 2019 //
ENDPOINTSNEWS
Penn team repurposes CAR-T cancer tech to treat heart disease
12 Sep 2019 //
FIERCE BIOTECH
Immatics shows Celgene isn`t done stocking cell therapy pipeline
29 Aug 2019 //
BIOPHARMADIVE
CMS will now cover pricey CAR-T therapies for Medicare patients
09 Aug 2019 //
ENDPTS
Gilead, Novartis cancer therapies losing patients to experimental treatments
30 Jul 2019 //
REUTERS
Zolgensma launch `on track and fully in line` with expectation, says CEO
19 Jul 2019 //
FIERCE PHARMA
Gilead touts CAR-T franchise with Yescarta analyses, early data on pipeline drug
04 Jun 2019 //
FIERCE PHARMA
Lovance unveils plans to build $75M cell therapy manufacturing plant
30 May 2019 //
ENDPTS
Novartis` Kymriah head jumps ship to T-cell biotech Atara
30 May 2019 //
FIERCE BIOTECH
Novartis exploring Saudi Arabia for production of cancer drugs
10 May 2019 //
FIERCE PHARMA
Novartis ready to meet even `unprecedented` demand for Zolgensm
09 May 2019 //
FIERCE PHARMA
Novel two-drug combo teaches immune system to attack cancer
08 Apr 2019 //
FIERCE BIOTECH
Pricing a hurdle for next-gen devices, but change is coming
06 Apr 2019 //
FIERCE BIOTECH
